Navigation Links
Ceregene And Alzheimer's Disease Cooperative Study Group Complete Enrollment Of CERE-110 Phase 2 Trial
Date:3/13/2013

SAN DIEGO, March 13, 2013 /PRNewswire/ -- Ceregene, Inc. today announced the completion of enrollment in its double-blind Phase 2 clinical study of CERE-110 (AAV-NGF), a gene therapy product designed to deliver nerve growth factor (NGF) for the treatment of Alzheimer's disease. The clinical study was carried out in collaboration with the Alzheimer's Disease Cooperative Study (ADCS) based at the University of California San Diego (UCSD) and funded by a grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH).  

Forty-nine (49) patients with mild to moderate Alzheimer's disease were treated with CERE-110 at 10 clinical sites throughout the U.S. Approximately half of the patients received CERE-110 while the other half received an appropriate sham (placebo) surgery control treatment. Patients will be followed for a minimum of two years with respect to safety, brain imaging, as well as measures of cognitive function and quality of life. Standard tests used in Alzheimer's clinical trials.

"We are very excited that enrollment in the first blinded study of NGF gene therapy for Alzheimer's disease is now completed and appreciate the courage of all of the patients and their family members that enrolled in this very important study. We also appreciate the efforts of the ADCS and the National Institute on Aging for carrying out and supporting the operational aspects of this study" stated Jeffrey M. Ostrove , Ph.D., president and chief executive officer of Ceregene, Inc., the developer of CERE-110. Dr. Ostrove added "In addition to CERE-110 for Alzheimer's disease, we have also completed enrollment in two controlled Phase 2 clinical trials of CERE-120 for Parkinson's disease. At this time, we would like to recognize the leadership role of Raymond T. Bartus , Ph.D., our chief scientific officer who led the development effor
'/>"/>

SOURCE Ceregene, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ceregene Parkinsons Disease Study Demonstrates Long-term Neurturin Expression and Enhanced Dopamine Activity 4 Years Following Delivery of CERE-120 (AAV2-neurturin)
2. Abattis Participates In Project On A Whole Plant Therapeutic For Treating Malaria And Other Diseases And Reducing Drug Resistance
3. Takeda Submits Marketing Authorisation Application for Vedolizumab in Moderately to Severely Active Ulcerative Colitis and Crohns Disease in the European Union
4. Alzheimers Drug Discovery Foundation Awards Grant To CohBar to Develop A Novel Peptide Therapeutic For Alzheimers Disease
5. Acquired Orphan Blood Diseases Therapeutics Market to 2019 - Search for Disease Modifying Drugs Central to Unlocking Premium Pricing Potential
6. Parkinsons Disease: World Drug Market 2013-2023
7. NeuroDerm Announces Positive Results of a Phase I Study of ND0612 for the Treatment of Parkinsons Disease
8. Adventrx To Develop ANX-188 For Complications Of Arterial Disease
9. Aethlon Medical (AEMD) Note: Multiple Shots on Goal - A Therapeutic Strategy to Address Infectious Disease & Cancer
10. Independent Study Published in Clinical Infectious Diseases Highlights the Importance of Antimicrobial Removal Systems in Blood Culture to Rapidly and Accurately Aid in the Diagnosis of Sepsis
11. Shire Supports Rare Disease Day 2013
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... 28, 2015 Codman Neuro*, part of DePuy ... new platform of embolic coils for the treatment of ... to improve microcatheter stability and provide an optimized detachment ... here at the Society of NeuroInterventional Surgery (SNIS) 12 ... framing, filling and finishing coils used during a minimally ...
(Date:7/28/2015)... Calif. , July 28, 2015 Amgen ... Directors today declared a $0.79 per share dividend for ... paid on Sept. 8, 2015, to all stockholders of ... 17, 2015.  About Amgen Amgen is ... suffering from serious illnesses by discovering, developing, manufacturing and ...
(Date:7/28/2015)... -- Insulet Corporation (NASDAQ: PODD ), the leader in ... Insulin Management System, today announced that Dr. Jessica ... Directors. Dr. Hopfield brings more than two ... She currently serves as the Vice Chair of the ... diabetes research center, diabetes clinic, and provider of diabetes ...
Breaking Medicine Technology:Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 2Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 3Codman Neuro Launches Family Of Coils For Treatment Of Brain Aneurysms 4Amgen Announces 2015 Third Quarter Dividend 2Amgen Announces 2015 Third Quarter Dividend 3Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 2Insulet Appoints Jessica Hopfield, PhD, to Board of Directors 3
... that a new market research report is available in ... Market: Facts and Figures2011   ... a time of political upheaval in many countries, this ... the economic, demographic and health structure of 18 Middle ...
... Pharmaceuticals (Nasdaq: SGNT ) announced the upsizing and ... offering has been increased from the previously announced 5,000,000 shares ... a price to the public of $16.00 per share. The ... Market on April 20, 2011 under the ticker symbol "SGNT." ...
Cached Medicine Technology:Reportlinker Adds Middle Eastern Medical Device Market: Facts and Figures2011 2Reportlinker Adds Middle Eastern Medical Device Market: Facts and Figures2011 3Sagent Pharmaceuticals Upsizes and Prices Initial Public Offering 2
(Date:7/28/2015)... ... July 28, 2015 , ... Mindful Her, a unique ... to take their healthy and mindful living practices to the next level, announced today ... of Living with Intent as keynote. Global Girls, an Orange County based non-profit ...
(Date:7/28/2015)... ... July 28, 2015 , ... The Denver Foundation and ... Reframed and Exhibited,” a photographic and narrative exploration of African American giving, which ... Points neighborhood. , Denver is one of only ten cities to host “The ...
(Date:7/28/2015)... ... 2015 , ... Representatives with CareMed Urgent & Primary Care ... National Immunization Awareness Month, which is the month of August. , “Immunization helps ... the flu, measles, and pneumonia, adults need to get their shots – just ...
(Date:7/28/2015)... FAIRFAX, Virginia (PRWEB) , ... July 28, 2015 , ... ... in the Washington, D.C. technology community for over 20 years, has selected Lisa Dezzutti, ... for the upcoming year. , “I am excited to serve this organization that empowers ...
(Date:7/28/2015)... Diego, California (PRWEB) , ... July 28, 2015 , ... ... more women consider the procedure to help ensure future fertility. As Dr. Michael ... June 2015), egg freezing is an option that wasn’t available for previous generations who ...
Breaking Medicine News(10 mins):Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 2Health News:Women’s Healthy Living Event Mindful Her Set for October 24, 2015 in Orange County 3Health News:"The Soul of Philanthropy Reframed and Exhibited” Comes to Denver 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 2Health News:CareMed Urgent & Primary Care Supports National Immunization Awareness Month 3Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 2Health News:Dr. Michael Kettel of San Diego Fertilty Center Interviewed by the San Diego Union-Tribune on Egg Freezing 3
... with mammography systems in the, early detection of ... false-positives and patient recalls by estimated 60 ... 14 Parascript, LLC, the image,analysis and pattern ... medical imaging market. With over a dozen years,experience ...
... voices of frustration from,those who live with the ... heard.,Recent studies suggest that the comprehensive and often ... the point,of inaction. Studies show that nearly 63% ... treatment goals. "Understanding the lengthy,and challenging process of ...
... Product Sales Total $3.1 Million in Quarter; Amoxicillin PULSYS ... Review Ongoing - PDUFA ... MiddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ), a pharmaceutical ... financial and operational results for the quarter ended September,30, ...
... NeoGenomics, Inc.,(OTC Bulletin Board: NGNM), a premier, high-complexity cancer ... of FY 2007.,Significant accomplishments during the third quarter and ... following: Third Quarter 2007 Accomplishments: -- 95% ... 06 -- 33% sequential growth in revenue from ...
... CTI,s new cancer drug development platform, SEATTLE, ... first-hand the progress and prospects of three of ... MTAX: CTIC) oncology drug,candidates, as well as information ... from an international panel of clinical investigators at ...
... ... Jordan, FREDERICK, Md., ... Jordan Food,& Drug Administration has cleared ActiPatch for sale. The Company has,initiated ... "We are proud to announce another step for our Company in ...
Cached Medicine News:Health News:Parascript Enters Medical Imaging Breast Cancer Detection Market With Established Image Analysis Technology 2Health News:Natural Antioxidants Help Reduce Oxidative Stress in Diabetes Treatment 2Health News:Natural Antioxidants Help Reduce Oxidative Stress in Diabetes Treatment 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 2Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 3Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 4Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 5Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 6Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 7Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 8Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 9Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 10Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 11Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 12Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 13Health News:MiddleBrook Pharmaceuticals Reports Third Quarter 2007 Results 14Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 2Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 3Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 4Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 5Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 6Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 7Health News:NeoGenomics Announces Results for the 3rd Quarter 2007 8Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 2Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 3Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 4Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 5Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 6Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 7Health News:Clinical Trial Investigators Update Wall Street on Progress and Prospects of Cell Therapeutics, Inc.'s Drug Pipeline 8Health News:ActiPatch(TM) Granted Market Clearance by the Food & Drug Administration in the Kingdom of Jordan 2
Autolensmeter with black/white monitor and no internal printer....
An ideal basic fundus fluorescein camera with quality enhancing features at a mid-range price point. The camera has 1.7x magnification at 60 degree and 2.5x at 40 degree....
... The Tomey TL-2000A Auto Lensmeter is ... advanced lens measuring features. In Auto mode, ... lens is properly aligned. Progressive lenses are ... you to correctly position the lens. The ...
... RC-XV3 camera is practical, compact ... automatic exposure system, the 22 ... 2.5~300ws watt indication and the ... the basic features to make ...
Medicine Products: